InvestorsHub Logo
icon url

epenephrine

09/16/14 9:10 AM

#34496 RE: birzinho #34495

The said in CC...they are selling the company for 40/share.....Are you serious...go to yahoo finance and type in AMRN..it will be under recent news articles....They plan on continuing R-IT....sNDA still under review......hope you didn't fall over in your chair with the intro......
icon url

DewDiligence

09/16/14 10:43 AM

#34507 RE: birzinho #34495

From CC: Expenditures on REDUCE-IT will run $30-40M annualized until enrollment is complete; after enrollment is complete, expenditures on R-IT will drop to slightly more than $30M annualized.

R-IT enrollment expected to be complete in 2015; interim data analysis at 60% of total event count expected in 2016; final (event-driven) analysis expected in 2017; reporting of full dataset at a medical conference expected in 2018.